Navigation Links
DIASTAT™ Anti-CCP

ProductsDIASTAT™ Anti-CCP
Company Inverness Medical Innovations
Item DIASTAT™ Anti-CCP
Features 
  • Diagnosis of RA in early synovitis patients
  • Differentiation of RA from other inflammatory arthritides
  • Differential diagnosis of RA from other connective tissue diseases such as erosive systemic lupus erythematosus
  • Confirmation of diagnosis in seronegative RA
  • Potential to identify patients who will develop a more severe form of RA at disease onset
  • Potential to monitor therapeutic effectiveness
Description A new highly sensitive and specific second-generation peptide-based test, DIASTAT Anti-CCP* is an ELISA based on the detection of autoantibodies against the cyclic citrullinated peptide (CCP) containing modified arginine residues in human serum or plasma. Enabling early and accurate diagnosis of RA, the Anti-CCP assay provides an additional tool in the diagnosis and management of patients with RA.
Info Inverness Medical Innovations
Customer Service: 800-257-9525
Web site: http://www.invernessmedical.com/

Related medicine products :

1. Wampole PreVue B. Burgdorferi Antibody Detection Assay
2. Wampole Impact Rubella Slide Test
3. Wampole Impact Syphilis RPR Test Kit
4. Wampole Impact Syphilis RPR® Test Kit
5. Wampole Rubella-plus Test Kit
6. Cogent Microbial Luminescence System
7. BD Affirm™ VPIII Microbial Identification Test
8. Silicone Oil Cannula System - 20 Gauge
9. Silicone Oil Cannula System - 19 Gauge
10. SuperVu Galilean System
11. KOWA nonmyd 7 / VK-2 Digital Imaging System
The Optima III 45 cm line of laparoscopic hand instruments is ideal for operative laparoscopic/endoscopic procedures or when a longer instrument is needed....
The ACMI™ line of laparoscopic hand instruments is designed to provide a wide selection of popular surgical devices to meet procedural needs....
Hook design lifts and separates tissue for efficient dissection. Cautery action facilitates immediate control of bleeders....
This probe coagulates bleeders while suction channel with trumpet valve simultaneously evacuates smoke....
Medicine Products:
(Date:5/5/2016)... ... May 05, 2016 , ... Qrono Inc. ... announced a development collaboration with the Australian critical medicine company, Phebra Pty ... schizophrenia. , LAI medicines can offer improved therapeutic benefits over oral formulations, including ...
(Date:5/5/2016)... (PRWEB) , ... May 05, 2016 , ... ... Tampa to offer patients with non-valvular atrial fibrillation (A-Fib) an alternative to long-term ... Since first offering the procedure in April of 2015, Florida Hospital Pepin Heart ...
(Date:5/5/2016)... Kansas (PRWEB) , ... May 05, 2016 , ... ... that some macroalgae can use ultraviolet light A (UV-A) for photosynthesis, researchers Juntian ... of red, green, and brown seaweeds. The pair observed that when photosynthetically active ...
(Date:5/5/2016)... ... May 05, 2016 , ... Derrin Doty Group has ... of Bremerton, Port Orchard and communities west of Seattle. The insurance provider’s caring team ... local girl who died suddenly due to complications from the flu, that they have ...
(Date:5/5/2016)... ... May 05, 2016 , ... The University of Western ... host the 2016 National SACA Leadership Conference on the Portland campus September 23-25. ... officers to come together and develop skills to be future leaders in the ...
Breaking Medicine News(10 mins):
(Date:5/5/2016)... 2016 Research and Markets has announced ... in the USA"  report to their offering.  ,     (Logo: ... the current Positron Emission Tomography (PET) scanner and cyclotron ... market. Along with the current known number of PET ... , the report also contains a detailed breakdown of ...
(Date:5/5/2016)... 5, 2016 ... of the  "Europe Thrombocytopenia Market and ... to their offering.       ... ,The latest research Europe Thrombocytopenia Market ... provides comprehensive insights into Thrombocytopenia pipeline ...
(Date:5/4/2016)... Conn., May 4, 2016  Compass Diversified Holdings (NYSE: ... "Company"), an owner of leading middle market businesses, announced ... ended March 31, 2016. First Quarter 2016 ... and Reinvestment ("CAD" or "Cash Flow") of $13.6 million ... net loss of $15.0 million for the first quarter ...
Breaking Medicine Technology: